John P. Brancaccio, Director at Cardiff Oncology, Inc. (CRDF), bought 6,993 shares at $1.43 ($10K) on 2020-05-14, disclosed to the SEC on 2020-05-18.
Open-market purchase of $10k CRDF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| HEPA | BUY | 2020-12-02 | $11K | — | Filing → |
| TROV | BUY | 2018-06-13 | $8K | — | Filing → |
| SGYP | BUY | 2017-05-30 | $23K | — | Filing → |